home / stock / ears / ears news

EARS News and Press, Auris Medical Holding AG From 07/30/19

Stock Information
Company Name: Auris Medical Holding AG
Stock Symbol: EARS
Market: NASDAQ
Menu
EARS EARS Quote EARS Short EARS News EARS Articles EARS Message Board
Get EARS Alerts

News, Short Squeeze, Breakout and More Instantly...
EARS - Auris Medical Announces Randomization of First Patient in AM-125 Phase 2 Trial in Acute Vertigo

Hamilton, Bermuda, July 30, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced that the first patien...
EARS - Auris Medical Completes Enrollment of Phase 1b Proof-Of-Concept Trial of AM-201 in Antipsychotic-Induced Weight Gain

Hamilton, Bermuda, July 03, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced that it has completed...

EARS - NVAX, AAOI among premarket gainers

Dova Pharmaceuticals (NASDAQ: DOVA ) +32%  as FDA OKs Dova's Doptelet for low blood platelets in ITP patients. More news on: Dova Pharmaceuticals, Inc., Atossa Genetics Inc., Zogenix, Inc., Stocks on the move, Read more ...

EARS - Auris updates on key upcoming milestones

In a update for investors, Auris Medical Holding ( EARS -1.7% ) lists the following key near-term events expected this year: More news on: Auris Medical Holding Ltd., Healthcare stocks news, Read more ...

EARS - Auris Medical Holding Ltd Provides Corporate Update

Hamilton, Bermuda, May 23, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today provided a business update, incl...

EARS - Auris Medical Holding Ltd Regains Compliance with Nasdaq Minimum Bid Price Rule

Hamilton, Bermuda, May 20, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders (the “Company”), announce...

EARS - Auris Medical Announces Closing of Public Offering of Common Shares

Hamilton, Bermuda, May 15, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, announced today the closing of its pre...
EARS - Auris Medical Announces Closing of Two US Patent Acquisitions Related to the Use of Betahistine for the Treatment of Depression and ADHD

Hamilton, Bermuda, May 15, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced the successful closing...

EARS - Cellectar Biosciences only healthcare gainer; INSYS Therapeutics leads the losers

Gainers:  Cellectar Biosciences (NASDAQ: CLRB ) +7% . More news on: Cellectar Biosciences, Inc., INSYS Therapeutics, Inc., Soliton, Inc., Healthcare stocks news, Stocks on the move, Read more ...

EARS - Auris Medical down 15% on equity offering

Thinly traded Auris Medical ( EARS -14.9% ) slumps on triple normal volume, albeit on turnover of only 403K shares, on reaction to its public equity offering . More news on: Auris Medical Holding Ltd., Healthcare stocks news, Stocks on the move, Read more ...

Previous 10 Next 10